MERRIMACK PHARMACEUTICALS INC Contracts & Agreements

First Amendment to Section 382 Rights Agreement (Filed With SEC on March 7, 2024)

Description of the Registrants Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 7, 2024)

Amendment to Section 382 Rights Plan dated December 2, 2022 (Filed With SEC on December 5, 2022)

Description of the Registrants Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 9, 2022)

Description of the Registrants Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 10, 2021)

Asset Purchase Agreement, dated as of March 27, 2020, between Merrimack Pharmaceuticals, Inc. and Celator Pharmaceuticals, Inc (Filed With SEC on March 30, 2020)

Description of the Registrants Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 12, 2020)

Section 382 Rights Agreement, dated as of December 3, 2019, between Merrimack Pharmaceuticals, Inc. and Computershare Trust Company, N.A., as Rights Agent (Filed With SEC on December 3, 2019)

Cooperation Agreement, dated as of September 18, 2019, by and among the Company, Newtyn Management, LLC, Newtyn Partners, LP, Newtyn TE Partners, LP, Noah G. Levy, Newtyn Capital... (Filed With SEC on September 20, 2019)

Stock Purchase Agreement, dated as of May 7, 2019, by and among the Registrant, HNKK Holdings Limited and Silver Creek Pharmaceuticals, Inc (Filed With SEC on July 17, 2019)

Separation and Release of Claims Agreement, dated as of April 12, 2019, by and between the Registrant and Sergio L. Santillana (Filed With SEC on July 17, 2019)

Transition, Separation and Release of Claims Agreement, dated as of June 25, 2019, by and between the Registrant and Daryl C. Drummond (Filed With SEC on July 17, 2019)

Transition, Separation and Release of Claims Agreement, dated as of June 25, 2019, by and between the Registrant and Jean M. Franchi (Filed With SEC on July 17, 2019)

Transition, Separation and Release of Claims Agreement, dated as of June 25, 2019, by and between the Registrant and Jeffrey A. Munsie (Filed With SEC on July 17, 2019)

Transition, Separation and Release of Claims Agreement, dated as of June 25, 2019, by and between the Registrant and Richard Peters (Filed With SEC on July 17, 2019)

Amendment No. 2 to Asset Purchase Agreement, dated as of June 28, 2019, between Merrimack Pharmaceuticals, Inc. and 14ner Oncology, Inc (Filed With SEC on July 1, 2019)

Amendment No 1. to Asset Purchase Agreement, dated as of June 24, 2019, between Merrimack Pharmaceuticals, Inc. and 14ner Oncology, Inc (Filed With SEC on June 24, 2019)

Asset Purchase Agreement, dated as of May 28, 2019, by and between Merrimack Pharmaceuticals, Inc. and 14ner Oncology, Inc (Filed With SEC on May 30, 2019)

Consent and Amendment No. 1 to Loan and Security Agreement, dated as of December 27, 2018, by and among the Registrant, the several banks and other financial institutions or... (Filed With SEC on March 6, 2019)

Loan and Security Agreement, dated as of July 2, 2018, by and among the Registrant, certain subsidiaries of the Registrant from time to time party thereto, the several banks and... (Filed With SEC on July 3, 2018)

Eighth Amendment of Lease, dated as of February 15, 2018, by and between the Registrant and ARE-MA Region No. 59, LLC (Filed With SEC on May 8, 2018)

Specimen certificate evidencing shares of common stock (Filed With SEC on March 12, 2018)

Scientific Advisory Board Consulting and Confidentiality Agreement, dated as of February 6, 2018, by and between the Registrant and George D. Demetri (Filed With SEC on March 12, 2018)

Seventh Amendment of Lease, dated as of February 6, 2018, by and between the Registrant and ARE-MA Region No. 59, LLC (Filed With SEC on March 12, 2018)

Employment Agreement, dated as of August 10, 2017, by and between the Registrant and Jean M. Franchi (Filed With SEC on November 8, 2017)

Employment Agreement, dated as of July 18, 2017, by and between the Registrant and Thomas E. Needham, Jr (Filed With SEC on November 8, 2017)

Stipulation and Agreement of Settlement and Release, dated October 6, 2017, among Wells Fargo Bank, National Association, Wolverine Flagship Fund Trading Limited, 1992 MSF... (Filed With SEC on October 10, 2017)

SIXTH AMENDMENT OF LEASE (Filed With SEC on August 9, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2017)

SUBLEASE AGREEMENT (Filed With SEC on May 10, 2017)

FIFTH AMENDMENT OF LEASE (Filed With SEC on May 10, 2017)

SEPARATION AND RELEASE OF CLAIMS AGREEMENT (Filed With SEC on May 10, 2017)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 1, 2017)

LOAN AND SECURITY AGREEMENT Dated as of November 8, 2016 between MERRIMACK PHARMACEUTICALS, INC. (as Borrower), and BIOPHARMA CREDIT INVESTMENTS IV SUB, LP (as Lender) LOAN AND... (Filed With SEC on March 1, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on March 1, 2017)

SEPARATION AND RELEASE OF CLAIMS AGREEMENT (Filed With SEC on March 1, 2017)

Amendment No. 8 to Sublease (Filed With SEC on March 1, 2017)

ASSETPURCHASE AND SALE AGREEMENT between MERRIMACK PHARMACEUTICALS, INC., a Delaware Corporation; and IPSEN S.A., aSociété Anonyme; Dated as of January 7, 2017 Table of Contents (Filed With SEC on January 9, 2017)

CONVERSION AGREEMENT (Filed With SEC on April 14, 2016)

AMENDMENT NO. 7 TO SUBLEASE (Filed With SEC on February 26, 2016)

MERRIMACK PHARMACEUTICALS, INC., as Issuer, and any Guarantorthat becomes party hereto pursuant to Section 4.10 hereof 11.5% Senior Secured Notes due 2022 INDENTURE Dated as... (Filed With SEC on December 22, 2015)

COLLATERAL AGREEMENT DATED AS OFDECEMBER 22, 2015 AMONG MERRIMACK PHARMACEUTICALS, INC., as Issuer, THE SUBSIDIARY PARTIESFROM TIME TO TIME PARTY HERETO U.S. BANK NATIONAL... (Filed With SEC on December 22, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2015)

FOURTH AMENDMENT OF LEASE (Filed With SEC on November 9, 2015)

THIRD AMENDMENT OF LEASE (Filed With SEC on February 27, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on February 27, 2015)

Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on February 27, 2015)

FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on February 27, 2015)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on November 10, 2014)

THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 10, 2014)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on June 30, 2014)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on March 4, 2014)

Amendment No. 6 to Sublease (Filed With SEC on March 4, 2014)

SECOND AMENDMENT OF LEASE (Filed With SEC on November 8, 2013)

MERRIMACK PHARMACEUTICALS, INC. and WELLS FARGO BANK, NATIONAL ASSOCIATION Trustee INDENTURE Dated as of July 17, 2013 SENIOR DEBT SECURITIES (Filed With SEC on July 18, 2013)

MERRIMACK PHARMACEUTICALS, INC. AND WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of July 17, 2013 4.50% Convertible Senior Notes due... (Filed With SEC on July 18, 2013)

J.P. MORGAN SECURITIES LLC MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED MERRIMACK PHARMACEUTICALS, INC. 4.50% Convertible Senior Notes due 2020 Underwriting Agreement (Filed With SEC on July 12, 2013)

Amendment, Consent and Waiver (Filed With SEC on July 12, 2013)

J.P. MORGAN SECURITIES LLC MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED MERRIMACK PHARMACEUTICALS, INC. 5,000,000 Shares of Common Stock, par value $0.01 per share... (Filed With SEC on July 12, 2013)

FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on March 20, 2013)

LOAN AND SECURITY AGREEMENT (Filed With SEC on November 14, 2012)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. RIGHT OF REVIEW AGREEMENT (Filed With SEC on August 14, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on January 13, 2012)

J.P. MORGAN SECURITIES LLC MERRIMACK PHARMACEUTICALS, INC. [] Shares of Common Stock, par value $0.01 per share Underwriting Agreement (Filed With SEC on January 13, 2012)

MERRIMACK PHARMACEUTICALS, INC. 2011 Stock Incentive Plan (Filed With SEC on January 13, 2012)

Vest Date (Filed With SEC on January 13, 2012)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. ASSIGNMENT, SUBLICENSE AND COLLABORATION AGREEMENT by... (Filed With SEC on October 26, 2011)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. LICENSE AGREEMENT Between Hermes Biosciences, Inc. And... (Filed With SEC on October 26, 2011)

Confidential Materials omitted and filed separately with the Securities and Exchang Commission. Asterisks denote omissions. PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT... (Filed With SEC on October 26, 2011)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 19, 2011)

MERRIMACK PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION AND REIMBURSEMENT POLICY (Filed With SEC on August 19, 2011)

Sublease By and Between FibroGen Inc. And Silver Creek (Filed With SEC on August 19, 2011)

INDEMNIFICATION AGREEMENT (Filed With SEC on August 19, 2011)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 19, 2011)

FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on July 8, 2011)

WARRANT AGREEMENT To Purchase Shares of the Series D Preferred Stock of Merrimack Pharmaceuticals, Inc. Dated as of April 6, 2005 (the Effective Date) (Filed With SEC on July 8, 2011)

Y (A-B) (Filed With SEC on July 8, 2011)

Form of warrant to purchase shares of Common Stock issued by the Registrant to HF HoldingABI, MS Seed Capital Partners, LP and Wren Holdings LLC Holder Number of shares HF... (Filed With SEC on July 8, 2011)

Form of warrant to purchase shares of Common Stock issued by the Registrant to General Electric Capital Corporation Issue date Number of shares 11/22/2006 797 11/22/2006 761... (Filed With SEC on July 8, 2011)

Form of warrant to purchase shares of Common Stock issued by the Registrant to various parties expiring on December 10, 2015 Holder Issue date Number of shares NG White Cloud, LLC... (Filed With SEC on July 8, 2011)

Form of warrant to purchase shares of Common Stock issued by the Registrant to various parties expiring on March 10, 2016 Holder Issue date Number of shares Brookbridge... (Filed With SEC on July 8, 2011)

Merrimack Pharmaceuticals, Inc. 1999 Stock Option Plan (as amended) (Filed With SEC on July 8, 2011)

MERRIMACK PHARMACEUTICALS, INC. 2008 STOCK INCENTIVE PLAN (as amended on April 6, 2011) (Filed With SEC on July 8, 2011)

Category

Industry

Companies

Contracts

MERRIMACK PHARMACEUTICALS INC Contracts & Agreements